.svg){kind=small}
Where to Buy
Zilla's is stocked at 38 licensed dispensaries across Michigan, with the deepest coverage in New Buffalo, Adrian, Menominee, Portage, and Baldwin. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Zilla's mix tilted toward Topical, which rose to 54.25% share with 280.79% year-over-year growth and 51.51% month-over-month, while Edible held 41.17% share with a -9.82% year-over-year decline but a 4.22% month-over-month gain; Tincture & Sublingual slipped to 4.58% share with -16.11% year-over-year and -83.63% month-over-month. The brand’s average price increased 69.29% year-over-year to $18.50 as Topical commanded a $25.24 average price versus Edible’s $13.27, and Zilla's ranked 7 in Topical in Michigan; the pattern implies a deliberate pivot toward higher-priced Topical driving overall sales growth while de-emphasizing Tincture & Sublingual.
The shift concentrates Zilla's positioning around premium-priced relief formats: Topical’s 51.51% month-over-month surge and 280.79% year-over-year expansion, paired with a 13.27–25.24 average price spread versus Edible, suggests margin prioritization over volume breadth, while the -83.63% month-over-month contraction in Tincture & Sublingual trims low-scale complexity. With Topical at 54.25% share and a rank of 7 in Michigan, and Edible stabilizing via a 4.22% month-over-month lift despite a -9.82% year-over-year slide, the implication is a focused ladder-up strategy: defend a top-10 Topical slot and use selective Edible recovery to diversify without diluting the Topical-led price architecture.
Competitive Landscape
Zilla's sits at rank #7 in MI Topical in August 2026 after climbing 6 positions from #13 year over year, and improving 4 spots from #11 since May 2026; this coincides with reaching a peak rank of #7 in August 2026 while the category leader Chill Medicated held at #1 with a 12.1% YoY sales increase and Mary's Medicinals stayed at #2 despite a 21.7% YoY sales decline. In the mid-pack, Vlasic Labs remained #4 while expanding sales by 58.6% YoY, and Rise (MI) held #3 with an 19.0% YoY sales contraction, indicating Zilla's gains are rank-driven against both advancing and contracting peers rather than tied to broad market lift; the trajectory from #13 to #7 implies Zilla's is consolidating a stable top-10 position with headroom to contest #5–#6 if the upward momentum from May 2026 to August 2026 persists.
Notable Products
CBD Assorted Gummy Butterflies (400mg CBD) posted the steepest movement in August 2026 with a -63.5% MoM decline while holding rank 8, contrasting with CBD Highly Effective Relief Cream (2000mg CBD, 2oz) up 27.7% at rank 1. CBD/CBN 1:1 Calm & Sleep CBN Gummy Bears 20-Pack (100mg CBD, 100mg CBN) fell 13.0% MoM at rank 4, whereas CBD Big Duck Dog Treats (1000mg CBD) rose 13.3% MoM at a shared rank 8. Four of the top ten are Edible SKUs while Topicals occupy ranks 1 and 3, implying a tilt toward topical-led velocity with selective edible retrenchment despite one edible outlier and a single topical leader generating $4,725.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
